Reply: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury?-Reference-Cited by-同舟云学术

Reply: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury?

Published:2024-03-05 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:

Author:

Roy Akash¹,Kajal Kamal²,Izzy Manhal³,Sihag Bhupendra K.⁴,Premkumar Madhumita⁵

Affiliation:

1. Department of Hepatology, Institute of Gastrosciences and Liver, Apollo Multispeciality Hospitals, Kolkata, West Bengal, India

2. Department of Anesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India

3. Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA

4. Department of Cardiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

5. Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference4 articles.

1. Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography;Premkumar;Hepatology,2023

2. Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: An analysis of cutoff values;Raevens;Liver Transpl,2013

3. Terlipressin improves pulmonary pressures in cirrhotic patients with pulmonary hypertension and variceal bleeding or hepatorenal syndrome;Kalambokis;Hepatobiliary Pancreat Dis Int,2012

4. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis;Narahara;J Gastroenterol Hepatol,2009